# Spasmodic Dysphonia Pain

> **NCT04648891** · PHASE2,PHASE3 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 32 (actual)

## Conditions studied

- Spasmodic Dysphonia

## Interventions

- **DRUG:** Lidocaine
- **DEVICE:** Vibrating wand

## Key facts

- **NCT ID:** NCT04648891
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-01
- **Primary completion:** 2023-07-01
- **Final completion:** 2023-07-01
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2024-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04648891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04648891, "Spasmodic Dysphonia Pain". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04648891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*